Apella Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
42,479
-674
-2% -$157K 0.16% 107
2026
Q1
$10.1M Buy
43,153
+11,736
+37% +$2.73M 0.15% 114
2025
Q4
$6.5M Buy
31,417
+930
+3% +$184K 0.13% 120
2025
Q3
$5.86M Buy
30,487
+1,659
+6% +$284K 0.13% 115
2025
Q2
$4.48M Buy
28,828
+1,179
+4% +$181K 0.12% 114
2025
Q1
$4.17M Buy
27,649
+3,314
+14% +$519K 0.14% 98
2024
Q4
$3.52M Buy
24,335
+348
+1% +$53.9K 0.14% 93
2024
Q3
$3.87M Buy
23,987
+752
+3% +$120K 0.16% 78
2024
Q2
$3.42M Buy
23,235
+3,855
+20% +$573K 0.15% 82
2024
Q1
$2.95M Sell
19,380
-83
-0.4% -$13.2K 0.15% 84
2023
Q4
$3.13M Buy
19,463
+6,164
+46% +$945K 0.17% 82
2023
Q3
$2.07M Sell
13,299
-208
-2% -$34.3K 0.15% 84
2023
Q2
$2.24M Buy
+13,507
New +$2.18M 0.16% 78
2022
Q4
$2.31M Buy
13,049
+3,774
+41% +$652K 0.21% 67
2022
Q3
$1.51M Sell
9,275
-768
-8% -$130K 0.18% 79
2022
Q2
$1.78M Buy
10,043
+1,371
+16% +$244K 0.21% 69
2022
Q1
$1.54M Buy
8,672
+260
+3% +$44.2K 0.22% 69
2021
Q4
$1.44M Buy
8,412
+1,216
+17% +$199K 0.18% 72
2021
Q3
$1.16M Sell
7,196
-886
-11% -$151K 0.17% 88
2021
Q2
$1.33M Sell
8,082
-566
-7% -$93.7K 0.22% 77
2021
Q1
$1.42M Buy
8,648
+122
+1% +$19.7K 0.45% 47
2020
Q4
$1.34M Sell
8,526
-630
-7% -$93K 0.47% 48
2020
Q3
$1.36M Buy
9,156
+49
+0.5% +$7.25K 0.55% 42
2020
Q2
$1.28M Buy
9,107
+100
+1% +$14.6K 0.6% 40
2020
Q1
$1.18M Buy
+9,007
New +$1.28M 0.69% 38

Other funds holding JNJ

Apella Capital's JNJ Position: Q2 2026 in Review

Apella Capital reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $157K and leaving 42,479 shares worth $11.4M. The position accounts for 0.16% of the portfolio, ranked #107.

Apella Capital first reported a position in JNJ in Q1 2020 and has held it in 25 quarters since. 1,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Apella Capital held 42,479 shares of Johnson & Johnson worth $11.4M as of Q2 2026.
  • Apella Capital sold 674 Johnson & Johnson shares in Q2 2026, an estimated $157K.
  • Johnson & Johnson made up 0.16% of Apella Capital's portfolio in Q2 2026, its #107 holding.
  • Apella Capital first reported a position in Johnson & Johnson in Q1 2020 and has held it in 25 quarters since.
  • 1,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.